Please assess the completion status of the following clinical trial:

Trial Title: Study to Assess Long-term Effectiveness of Zomacton® and Treatment Adherence in Patients With Growth Hormone Deficiency or Ullrich-Turner Syndrome

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Pediatric patients (\< 18 years) with growth hormone deficiency or growth retardation due to Ullrich-Turner-Syndrome~* Patients already receiving or who have been prescribed Zomacton® de novo according to its German label; the decision to prescribe Zomacton® was made independently from participation and prior to enrollment in this study.~* Patient and their parents (or legal representatives) who are willing and able to provide signed informed consent for use of their personal data.~Exclusion Criteria:~* Participation in an interventional clinical study within the last 30 days prior to baseline visit or during the follow-up period

- Gender: ALL
- Minimum Age: None
- Maximum Age: 18 Years
- Healthy Volunteers: f

Study Arms:
- Zomacton (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).